CompletedPhase 3NCT01838551
Treatment for Endogenous Cushing's Syndrome
Studying OBSOLETE: Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cortendo AB
- Principal Investigator
- Fredric J Cohen, MDCortendo AB
- Intervention
- Levoketoconazole(drug)
- Enrollment
- 94 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2018
Study locations (30)
- UCLA School of Medicine, Los Angeles, California, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- University of New Mexico HSC, Albuquerque, New Mexico, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- Allegheny Neuroendocrinology Center, Pittsburgh, Pennsylvania, United States
- University Hospitals Leuven Department of Endocrinology, Leuven, Belgium
- University Specialized Hospital for Active Treatment in Endocrinology (USHATE), Sofia, Bulgaria
- St. Pauls Hospital/Vancouver General Hospital, Vancouver, British Columbia, Canada
- Vseobecna fakultni nemocnice v Praze - III. Interni klinika VFN a 1. LF UK, Prague, Czechia
- Aarhus University Hospital, Aarhus, Denmark
- Rigshospitalet,Copenhagen University Hospital, Copenhagen, Denmark
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01838551 on ClinicalTrials.govOther trials for OBSOLETE: Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07296484Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Sparrow Pharmaceuticals
- RECRUITINGNCT07156370Salivary Cortisol and Hypercortisolism in Type 2 DiabetesShanghai 6th People's Hospital
- RECRUITINGPHASE1, PHASE2NCT07350707Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromePeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGNANCT05315388Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of BogotáJeadran N. Malagón-Rojas
- ACTIVE NOT RECRUITINGNCT05382156Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's SyndromeRECORDATI GROUP
- RECRUITINGNANCT05368090Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary AldosteronismHaukeland University Hospital